Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00200070 · ClinicalTrials.gov registry record · Phase 3

Neurostimulation to Treat Refractory Angina Pectoris Pain

A Phase 3 study, sponsored by MedtronicNeuro.

Terminated
Registry status
Phase 3
Development phase
228
Enrollment target

NCT00200070: Clinical Trial Phase 3 study, sponsored by MedtronicNeuro.

NCT00200070 is a Phase 3 study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 228 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00200070, a Phase 3 study, was terminated before completion, sponsored by MedtronicNeuro.

TERMINATED
Registry status
Phase 3
Development phase
228 participants
Enrollment target

Study Summary

The therapy under investigation involves an implanted Medtronic neurostimulation system to relieve symptoms of angina pectoris pain. Electrical impulses are applied to targeted areas of the spinal cord through an implanted lead (a flexible insulated wire) that is powered by an implanted battery.

Interventions

  • DEVICE Spinal Cord Stimulation

Trial Details

FieldValue
Enrollment Target 228 participants
Start Date 2002-12
Est. Completion 2007-04
Phase Phase 3
MedtronicNeuro

51 total trials

Why NCT00200070 stopped before completion

NCT00200070 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower).

The record links to 0 conditions, and to 1 intervention - of which Spinal Cord Stimulation is the first listed.

NCT00200070 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00200070 about?

NCT00200070 is a clinical study titled "Neurostimulation to Treat Refractory Angina Pectoris Pain". The therapy under investigation involves an implanted Medtronic neurostimulation system to relieve symptoms of angina pectoris pain. Electrical impulses are applied to targeted areas of the spinal cord through an implanted lead (a flexible insulated wire) that is powered by an implanted battery.

What is the current status of trial NCT00200070?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 228 participants. The study started on 2002-12. Estimated completion is 2007-04.

What interventions are being tested in trial NCT00200070?

The interventions under investigation include: Spinal Cord Stimulation (DEVICE).

Who is sponsoring clinical trial NCT00200070?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00200070's enrollment target sits among peer trials

228 1309th of 2000 higher than 691 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05107908 · 228 participants · NA

    Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

  • NCT05547698 · 228 participants · NA

    A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation

  • NCT05630963 · 228 participants

    Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

  • NCT06073665 · 228 participants · Phase 4

    Dosing of LT4 in Older Individuals

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00200070, the US trial registry maintained by the National Library of Medicine. NCT00200070 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.